Pre-clinical studies have also demonstrated that the combination of HPV16 E7 DNA-based therapeutic vaccines with co-blockade of PD-1/PD-L1 signaling in E6- and E7-expressing transplantable TC-1 tumor bearing mice can significantly enhance the tumor -specific CTL response and improve tumor regression [134], [135], [136]. The gene discussed is CD274; the disease is neoplasm.